BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27458587)

  • 1. Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data.
    Grissa D; Pétéra M; Brandolini M; Napoli A; Comte B; Pujos-Guillot E
    Front Mol Biosci; 2016; 3():30. PubMed ID: 27458587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative investigation of modern feature selection and classification approaches for the analysis of mass spectrometry data.
    Gromski PS; Xu Y; Correa E; Ellis DI; Turner ML; Goodacre R
    Anal Chim Acta; 2014 Jun; 829():1-8. PubMed ID: 24856395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A random forest based biomarker discovery and power analysis framework for diagnostics research.
    Acharjee A; Larkman J; Xu Y; Cardoso VR; Gkoutos GV
    BMC Med Genomics; 2020 Nov; 13(1):178. PubMed ID: 33228632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustness of chemometrics-based feature selection methods in early cancer detection and biomarker discovery.
    Lee HW; Lawton C; Na YJ; Yoon S
    Stat Appl Genet Mol Biol; 2013 Mar; 12(2):207-23. PubMed ID: 23502343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SVM-RFE: selection and visualization of the most relevant features through non-linear kernels.
    Sanz H; Valim C; Vegas E; Oller JM; Reverter F
    BMC Bioinformatics; 2018 Nov; 19(1):432. PubMed ID: 30453885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Feature Selection Approach Guided an Early Prediction of Anthocyanin Accumulation Using Massive Untargeted Metabolomics Data in Mulberry.
    Yu C; Dong Z; Jemaa E; Zhu Z; Mo R; Li Y; Deng W; Hu X; Zhang C; Han G
    Plant Cell Physiol; 2022 May; 63(5):671-682. PubMed ID: 35247053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evolving computational platform for biological mass spectrometry: workflows, statistics and data mining with MASSyPup64.
    Winkler R
    PeerJ; 2015; 3():e1401. PubMed ID: 26618079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Conversation on Data Mining Strategies in LC-MS Untargeted Metabolomics: Pre-Processing and Pre-Treatment Steps.
    Tugizimana F; Steenkamp PA; Piater LA; Dubery IA
    Metabolites; 2016 Nov; 6(4):. PubMed ID: 27827887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable importance analysis based on rank aggregation with applications in metabolomics for biomarker discovery.
    Yun YH; Deng BC; Cao DS; Wang WT; Liang YZ
    Anal Chim Acta; 2016 Mar; 911():27-34. PubMed ID: 26893083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive workflow of mass spectrometry-based untargeted metabolomics in cancer metabolic biomarker discovery using human plasma and urine.
    Zou W; She J; Tolstikov VV
    Metabolites; 2013 Sep; 3(3):787-819. PubMed ID: 24958150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. biosigner: A New Method for the Discovery of Significant Molecular Signatures from Omics Data.
    Rinaudo P; Boudah S; Junot C; Thévenot EA
    Front Mol Biosci; 2016; 3():26. PubMed ID: 27446929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust biomarker discovery for hepatocellular carcinoma from high-throughput data by multiple feature selection methods.
    Zhang Z; Liu ZP
    BMC Med Genomics; 2021 Aug; 14(Suppl 1):112. PubMed ID: 34433487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local false discovery rate estimation using feature reliability in LC/MS metabolomics data.
    Chong EY; Huang Y; Wu H; Ghasemzadeh N; Uppal K; Quyyumi AA; Jones DP; Yu T
    Sci Rep; 2015 Nov; 5():17221. PubMed ID: 26596774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting Feature Subsets Based on SVM-RFE and the Overlapping Ratio with Applications in Bioinformatics.
    Lin X; Li C; Zhang Y; Su B; Fan M; Wei H
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29278382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of feature selection methods for biomarker discovery in clinical proteomics.
    Christin C; Hoefsloot HC; Smilde AK; Hoekman B; Suits F; Bischoff R; Horvatovich P
    Mol Cell Proteomics; 2013 Jan; 12(1):263-76. PubMed ID: 23115301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive Modeling for Metabolomics Data.
    Ghosh T; Zhang W; Ghosh D; Kechris K
    Methods Mol Biol; 2020; 2104():313-336. PubMed ID: 31953824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance evaluate of different chemometrics formalisms used for prostate cancer diagnosis by NMR-based metabolomics.
    Oliveira MF; de Albuquerque Neto MC; Leite TS; Alves PAA; Lima SVC; Silva RO
    Metabolomics; 2023 Dec; 20(1):8. PubMed ID: 38127222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive evaluation of untargeted metabolomics data processing software in feature detection, quantification and discriminating marker selection.
    Li Z; Lu Y; Guo Y; Cao H; Wang Q; Shui W
    Anal Chim Acta; 2018 Oct; 1029():50-57. PubMed ID: 29907290
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.